반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/임상시험 | Q1 Claimed the Highest Number of Trial Starts in 2022 | 03-31-2023 |
| Emerging Market Outsourcing Report – Q1 2023 | 03-31-2023 | |
| Reinforcement for AbbVie’s Skyrizi and Promise for Takeda’s TAK-279 in Plaque Psoriasis at AAD 2023 | 03-31-2023 | |
| Bio/Pharmaceutical Outsourcing Report, March 2023 | 03-31-2023 | |
| Latest WHO COVID-19 Vaccine Guidance May Decrease Future Demand | 03-31-2023 | |
| AD/PD 2023: Lecanemab Quality of Life Data Highlights Value for Patients and Caregivers | 03-31-2023 | |
| AD/PD 2023: Lilly Highlights Potential Durability of Treatment with Donanemab | 03-31-2023 | |
| 질환별 |
Obsessive-Compulsive Disorder (OCD): Competitive Landscape | 03-31-2023 |
| Myelofibrosis: Eight-Market Drug Forecast and Market Analysis | 03-31-2023 | |
| Obesity: 68-Market Analysis and Sales Forecast | 03-31-2023 | |
| Unmet Needs in the Lupus Market | 03-31-2023 | |
| Mucopolysaccharidosis II (MPS II): Competitive Landscape | 03-31-2023 | |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.12(금) (0) | 2023.08.18 |
|---|---|
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 04.28(금) (0) | 2023.08.18 |
| 임상시험 타당성 조사(Feasibility) 지원사업 (0) | 2023.06.22 |
| 2023 ASCO(미국임상종양학회) 사절단 참여기업 모집 (0) | 2023.04.25 |
| 2023년 CRO 기관인증 및 컨설팅 지원사업 공고 (0) | 2023.03.15 |